Thalassemia gene therapy nears approval

Overview of attention for news story in Nature Biotechnology

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 335,618 followers.

RT @NatureBiotech: .@bluebirdbio's thalassemia #genetherapy #Zynteglo nears approval https://t.co/sluGQJeLUT

Reply Repost Favourite

RT @NatureBiotech: .@bluebirdbio's thalassemia #genetherapy #Zynteglo nears approval https://t.co/sluGQJeLUT

Reply Repost Favourite

RT @NatureBiotech: .@bluebirdbio's thalassemia #genetherapy #Zynteglo nears approval https://t.co/sluGQJeLUT

Reply Repost Favourite

WOULD THIS BE THE FIRST SUPERENHANCER-CONTAINING THERAPY? ATTN @epigenetichulk

Reply Repost Favourite

RT @NatureBiotech: .@bluebirdbio's thalassemia #genetherapy #Zynteglo nears approval https://t.co/sluGQJeLUT

Reply Repost Favourite

.@bluebirdbio's thalassemia #genetherapy #Zynteglo nears approval https://t.co/sluGQJeLUT

Reply Repost Favourite